Quarterly
Annual
| Unit: USD | 2024-03-31 | 2022-06-30 | 2022-03-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|
cash flows from operating activities | ||||||
net income / | 14,400,000 | |||||
adjustments to reconcile net income / (loss) to net cash from / (used in) operating activities: | ||||||
non-cash compensation expense related to stock based employee and directors' compensation | 1,800,000 | |||||
depreciation of non-current assets | 31,800,000 | 0 | 29,500,000 | 28,400,000 | 26,400,000 | 28,400,000 |
amortization of deferred mobilization and contract preparation costs | 14,700,000 | |||||
amortization of deferred mobilization, demobilization and other revenue | -26,200,000 | |||||
gain on disposal of assets | -200,000 | -3,600,000 | -800,000 | |||
amortization of debt discount | 1,700,000 | |||||
amortization of debt premium | -100,000 | |||||
amortization of deferred finance charges | 2,700,000 | 0 | 1,600,000 | 1,500,000 | 1,900,000 | 1,100,000 |
effective interest rate adjustments | -300,000 | 3,100,000 | 400,000 | 700,000 | 1,000,000 | |
income from equity method investments | -5,400,000 | -1,100,000 | -3,800,000 | |||
deferred income tax | -3,100,000 | 1,200,000 | -100,000 | 100,000 | -500,000 | -300,000 |
change in assets and liabilities: | ||||||
amounts due to/from related parties | -3,200,000 | 3,700,000 | -11,100,000 | -10,900,000 | 100,000 | 4,600,000 |
accrued expenses | -9,300,000 | -36,000,000 | 60,800,000 | 13,700,000 | -900,000 | 1,200,000 |
accrued interest | 35,100,000 | |||||
other current and non-current assets | -45,800,000 | -4,900,000 | -23,600,000 | 7,600,000 | -6,500,000 | 7,100,000 |
other current and non-current liabilities | 15,000,000 | -10,300,000 | 21,300,000 | -9,400,000 | 7,000,000 | -6,300,000 |
net cash from / (used in) operating activities | 23,900,000 | |||||
cash flows from investing activities | ||||||
purchase of property, plant and equipment | -200,000 | |||||
additions to newbuildings | -3,300,000 | |||||
additions to jack-up drilling rigs | -15,200,000 | |||||
net cash from investing activities | -18,700,000 | -5,700,000 | ||||
cash flows from financing activities | ||||||
repayment of debt | -10,600,000 | |||||
cash dividends paid | -23,800,000 | |||||
debt proceeds, gross of premium / (net of discount) and issuance costs | 208,300,000 | |||||
proceeds from exercise of share options | 1,300,000 | |||||
net cash from financing activities | 175,200,000 | -30,500,000 | 34,100,000 | 44,800,000 | ||
net increase in cash, cash equivalents and restricted cash | 180,400,000 | 12,300,000 | 36,500,000 | -16,600,000 | 29,800,000 | |
cash, cash equivalents and restricted cash at the beginning of the period | 102,600,000 | 12,300,000 | 46,000,000 | 32,400,000 | 49,000,000 | 19,200,000 |
cash, cash equivalents and restricted cash at the end of the period | 283,000,000 | -20,500,000 | 58,300,000 | |||
supplementary disclosure of cash flow information | ||||||
interest paid | -6,300,000 | |||||
income taxes paid | -12,800,000 | -3,400,000 | -1,600,000 | -800,000 | ||
adjustments to reconcile net income / (loss) to net cash provided by/(used in) operating activities: | ||||||
non-cash compensation expense related to stock based and directors' compensation | ||||||
impairment of non-current assets | ||||||
gain on disposal of assets and other non-operating income | ||||||
bank commitment, guarantee and other fees | ||||||
change in assets and liabilities | ||||||
net cash (used in) / provided by operating activities | ||||||
proceeds from sale of fixed assets | 800,000 | 1,400,000 | ||||
repayment from / (funding provided to) equity method investments | ||||||
proceeds from disposal of equity method investments | ||||||
net cash (used in) / provided by investing activities | ||||||
proceeds from share issuance, net of issuance costs | ||||||
proceeds from debt, net of discount and issuance costs | ||||||
purchase of treasury shares | ||||||
net (decrease) / increase in cash, cash equivalents and restricted cash | ||||||
cash, cash equivalents and restricted cash at beginning of the year | ||||||
cash, cash equivalents and restricted cash at end of the year | ||||||
net income | -114,000,000 | -51,300,000 | -32,600,000 | -59,900,000 | -54,400,000 | |
adjustments to reconcile net income to net cash from operating activities: | ||||||
non-cash compensation expense related to stock options | -100,000 | 300,000 | 200,000 | 200,000 | 700,000 | |
loss/(income) from equity method investments | 5,700,000 | |||||
long-term accrued interest | 41,000,000 | -44,100,000 | 1,400,000 | 15,700,000 | 16,100,000 | |
net cash from operating activities | 6,200,000 | -14,700,000 | -7,000,000 | -10,900,000 | -16,700,000 | |
capex | 0 | 0 | 0 | 0 | 0 | |
free cash flows | 6,200,000 | -14,700,000 | -7,000,000 | -10,900,000 | -16,700,000 | |
purchase of plant and equipment | ||||||
investments in equity method investments | 38,700,000 | -1,600,000 | 3,100,000 | |||
additions to jack-up rigs | -8,800,000 | -7,100,000 | -5,800,000 | -4,900,000 | -2,800,000 | |
proceeds from share issuance, net of issuance cost | -30,500,000 | 34,100,000 | 44,800,000 | |||
net (decrease)/increase in cash, cash equivalents and restricted cash | ||||||
interest paid, net of capitalized interest | -7,900,000 | -7,100,000 | -11,200,000 | -13,700,000 | -9,500,000 | |
net cash (used in)/from investing activities | -7,100,000 | |||||
amortization of acquired contract backlog | ||||||
unrealized loss on financial instruments | ||||||
(income)/income from equity method investments | ||||||
non-cash loan fees related to settled debt | ||||||
long term accrued interest | ||||||
purchase of financial instruments and marketable debt securities | ||||||
repayment of/(funding provided by) shareholder loan | ||||||
proceeds from sale of financial instruments and marketable debt securities | ||||||
net cash provided by/(used in) investing activities | ||||||
proceeds from share issuance, net of issuance costs and conversion of shareholders' loans | ||||||
repayment of long-term debt | ||||||
proceeds, net of deferred loan costs, from issuance of long-term debt | ||||||
proceeds, net of deferred loan costs, from issuance of short-term debt | ||||||
net increase in cash and cash equivalents and restricted cash | ||||||
cash and cash equivalents and restricted cash at beginning of the period | ||||||
cash and cash equivalents and restricted cash at end of the period | ||||||
income taxes refunded (paid) | 2,000,000 | 1,600,000 | ||||
issuance of long-term debt as non-cash settlement for deferred amendments | ||||||
issuance of long-term debt as non-cash settlement for newbuild delivery installment | ||||||
non-cash offset in respect of jack-up drilling rigs | ||||||
change in fair value of financial instruments | ||||||
purchase of marketable securities | ||||||
disposal of equity method investments | 10,600,000 | |||||
proceeds from sale of marketable securities | ||||||
net cash from/(used in) investing activities | 43,500,000 | |||||
proceeds, net of deferred loan cost, from issuance of long-term debt | ||||||
cash and cash equivalents at the end of period | 68,900,000 | 32,400,000 | ||||
loss / (gain) on disposal of assets | 100,000 | |||||
(income) / income from equity method investments | -16,000,000 | |||||
net cash provided by/(used) in investing activities | 1,700,000 | |||||
cash, cash equivalents and restricted cash at the end of period | 49,000,000 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
